☆ 4.5 Article

The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas

PATHOLOGY RESEARCH AND PRACTICE (2024)

Related references

Note: Only part of the references are listed.

Article Pathology

Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases

Hui Li et al.

Summary: FH-d uSMTs typically exhibit distinct morphological features and a high frequency of FH germline mutations. The combination of predictive morphology evaluation, FH immunotype, and molecular testing is helpful for screening HLRCC in uSMTs.

HUMAN PATHOLOGY (2022)

Add to Collection

Review Oncology

Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening

Karuna Garg et al.

Summary: HLRCC is a genetic syndrome associated with an increased risk for renal cell carcinoma and smooth muscle tumors. By evaluating tumor morphology, FH deficiency can be identified in USMT, guiding patients towards formal genetic counseling.

GENES CHROMOSOMES & CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

A prognostic index model for predicting long-term recurrence of uterine leiomyoma after myomectomy

Xiu Ming et al.

Summary: The study proposed a prognostic index (PI) model for predicting the long-term recurrence risk of uterine leiomyoma (UL) after myomectomy. The model categorized patients into low-risk, intermediate-risk, and high-risk groups based on PI values, with significant differences in recurrence risk observed between these groups in both internal and external validation groups. The model proved to be effective in predicting UL recurrence after myomectomy.

PLOS ONE (2021)

Add to Collection

Review Oncology

Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature

Yanfei Yu et al.

Summary: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a genetic syndrome characterized by cutaneous and uterine leiomyomas, as well as an increased risk of developing renal cell carcinoma (RCC). This study identified novel FH mutations in Chinese patients with HLRCC-related RCC, suggesting the importance of germline screening in early-onset cases. The findings provide valuable clinical information for the differential diagnosis of HLRCC-associated RCC.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Add to Collection

Article Cell Biology

Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients

Chengbao Liu et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Oncology

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization

A. Beatriz Sanchez-Heras et al.

CANCERS (2020)

Add to Collection

Article Oncology

Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations

Jia Xie et al.

GENES CHROMOSOMES & CANCER (2018)

Add to Collection

Article Genetics & Heredity

Fumarase deficiency: a rare disorder on the crossroads of clinical and metabolic genetics, neurology and cancer

Charushree Prasad et al.

CLINICAL DYSMORPHOLOGY (2017)

Add to Collection

Article Pathology

Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings

Wesley J. Harrison et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Add to Collection

Article Urology & Nephrology

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours

Peter A. Humphrey et al.

EUROPEAN UROLOGY (2016)

Add to Collection

Article Obstetrics & Gynecology

Long-term risk of fibroid recurrence after laparoscopic myomectomy

M. P. Radosa et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)

Add to Collection

Article Pathology

Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry

Carolina Reyes et al.

MODERN PATHOLOGY (2014)

Add to Collection

Article Oncology

Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status

Chiara Bardella et al.

JOURNAL OF PATHOLOGY (2011)

Add to Collection

Article Obstetrics & Gynecology

Predictors of leiomyoma recurrence after laparoscopic myomectomy

Eun-Hee Yoo et al.

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2007)

Add to Collection

Article Pathology

The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome

Maria J. Merino et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Add to Collection

Article Genetics & Heredity

Mutations in the Fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

JR Toro et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)

Add to Collection

Article Genetics & Heredity

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

IPM Tomlinson et al.

NATURE GENETICS (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.